Septerna, Inc. (SEPN) — Stock Score Summary

Septerna, Inc. (SEPN) has a MoatMap StockRank of 59/100 based on Quality (46/100), Value (37/100), and Momentum (61/100) factor scores. The current signal is HOLD. Septerna is a clinical-stage biotech company. While its GPCR platform is scientifically interesting, it is pre-revenue and lacks the predictable cash flows and margin of safety required by our lenses.

Septerna, Inc. is a biotechnology company focused on discovering and developing novel small molecule medicines targeting G protein-coupled receptors (GPCRs). It leverages a proprietary drug discovery platform designed to identify new small molecule candidates for challenging GPCR targets, aiming to address unmet medical needs. Septerna is a clinical-stage biotechnology company with a specialized focus on GPCR drug discovery, utilizing a unique platform to unlock new therapeutic avenues.

Key Financial Metrics

Price$31.01
Market Cap$1.4B
P/E (Forward)-11.80
Price/Book3.68
Return on Equity-9.3%
Return on Invested Capital-15.9%
Debt/Equity6.10
Gross Margin100.0%
Operating Margin-50.1%
Revenue Growth12011.0%
Free Cash Flow$24M

Septerna, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Septerna, Inc.’s (SEPN) StockRank?
MoatMap’s StockRank for Septerna, Inc. (SEPN) is 59/100, with a Hold signal. It is a composite of Quality (46), Value (37), and Momentum (61) factor ranks across MoatMap’s 19,000+ stock universe.
Does Septerna, Inc. have an economic moat?
Septerna, Inc. (SEPN) has a Quality factor score of 46/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Septerna, Inc. a buy, hold, or sell?
MoatMap’s current signal for Septerna, Inc. (SEPN) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Septerna, Inc. in?
Septerna, Inc. (SEPN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSEPN deep dive reportAI ChampionsHow we score stocksSense-check another stock